When was MBC Pharma founded?

MBC Pharma was founded in 2005 and raised its 1st funding round within a year of its incorporation.

Where is MBC Pharma located?

MBC Pharma is headquartered in Aurora, United States.

How many employees does MBC Pharma have?

As of May 31, 2026, the latest employee count at MBC Pharma is 5.

Is MBC Pharma a funded company?

MBC Pharma is a funded company, having raised an undisclosed amount across 9 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 01, 2005.

When was the latest funding round of MBC Pharma?

MBC Pharma's latest funding was a $***** Grant (prize money) round on Nov 19, 2021, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $891M in funding in 2026 to date.

Where does MBC Pharma rank among its competitors?

MBC Pharma ranks 3479th amongst 5155 active competitors, of which 1543 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Immuneel, which secured $10.5M in Jun, 2026.

Who are the top competitors of MBC Pharma?

MBC Pharma's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Among them, Immuneel secured the most recent funding round in June, 2026.

MBC Pharma - 2026 Company Profile, Team, Funding & Competitors

Company Details

MBC Pharma is an early-stage biotech, developing drugs for oncology, bone and infectious diseases. Its drug development is based on a proprietary platform. Its platform for Cancer-Induced Bone Disease And Bone Cancers works by combining a known bone-targeting drug (bisphosphonate) with known anti-cancer drugs. This helps them target the bone cancer microenvironment, and thus increasing specificity and reducing unwanted side-effects. The second platform links vitamins (such as B6) to a drug of interest, to develop treatments for Oncology and Viral Diseases.

Website: mbcpharma.com
Email ID: *****@mbcpharma.com
Phone Number: +1 **********

Key Metrics

Founded Year

2005

Location

Aurora, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Nov 19, 2021, $*****

Investors

CBSA & 1 more

Ranked

3479^th among 5155 active competitors

Employee Count

5 as on May 31, 2026

Similar Companies

Jazz Pharmaceuticals & 5535 more

View MBC Pharma's full profile

MBC Pharma has raised funding over 9 rounds. Its first funding round was on Mar 01, 2005. Its latest funding round was a Grant (prize money) round on Nov 19, 2021 for $*****. 1 investor participated in its latest round. MBC Pharma has 2 institutional investors.

Here is the list of recent funding rounds of MBC Pharma:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 19, 2021	8756444	Grant (prize money)	8877653	6473972	3582779	6991365
Aug 07, 2017	6529177	Grant (prize money)	3115746	9296963	3568734	HHS
Feb 01, 2016	6576951	Grant (prize money)	6464483	9746843	4673889	HHS

Access funding benchmarks and valuations. Sign up today!

View details of MBC Pharma's funding rounds and investors

MBC Pharma's employee count trend

MBC Pharma has 5 employees as of May 26. Here is MBC Pharma's employee count trend over the years:

Uncover MBC Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MBC Pharma include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of MBC Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, Google Ventures & 17 others	75/100
3rd	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
4th	Senti Bio 2016, San Francisco (United States), Public	Developer of cell and gene therapies for patients living with incurable diseases	$158M	Celadon Partners, New Enterprise Associates ... & 30 others	72/100
5th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
6th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
7th	Karyopharm 2008, Newton (United States), Public	Biopharmaceutical company focused on developing and commercializing innovative cancer therapies	$98.4M	Foresite Capital, Avidity Partners & 16 others	72/100
8th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, AstraZeneca & 32 others	71/100
9th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	True North, F-Prime Capital & 23 others	71/100
10th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
3479th	MBC Pharma 2005, Aurora (United States), Funding Raised	Early-stage biotech developing drugs for oncology, bone and infectious diseases.	-	CBSA, HHS	25/100